Rangeley Capital, LLC Repare Therapeutics Inc. Transaction History
Rangeley Capital, LLC
- $83.8 Billion
- Q2 2025
A detailed history of Rangeley Capital, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Rangeley Capital, LLC holds 355,292 shares of RPTX stock, worth $554,255. This represents 0.59% of its overall portfolio holdings.
Number of Shares
355,292Holding current value
$554,255% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
56Shares Held
30.8MCall Options Held
163KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$16.1 Million0.56% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.37 Million2.59% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.18 Million0.16% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.63 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.13 Million6.53% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $65.4M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...